OH2 clinical trials
How each study uses OH2 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the OH2 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
8 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Binhui Biopharmaceutical Co., Ltd. (8)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test OH2.
- Jul 2027OH2 Administered by Intratumoral InjectionPhase 1 · Binhui Biopharmaceutical Co., Ltd.
Studies
Open first, then newest update. How each study uses OH2 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- OH2 Injection in Combination With HX008 for Melanoma.RecruitingPhase 1/2Binhui Biopharmaceutical Co., Ltd.NCT04616443Written as OH2 injection
- OH2 Administered by Intratumoral InjectionNot yet recruitingPhase 1Binhui Biopharmaceutical Co., Ltd.NCT05954091Written as OH2 Injection
- OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver CancerRecruitingPhase 1Binhui Biopharmaceutical Co., Ltd.NCT05698459Written as OH2 injection
- OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder CancerRecruitingPhase 1/2Binhui Biopharmaceutical Co., Ltd.NCT05232136Written as OH2 injection
- OH2 Injection in Solid TumorsCompletedPhase 1/2Binhui Biopharmaceutical Co., Ltd.NCT04386967Written as OH2 injection
- OH2 Oncolytic Viral Therapy in Central Nervous System TumorsCompletedPhase 1/2Binhui Biopharmaceutical Co., Ltd.NCT05235074Written as OH2 injection
- OH2 Oncolytic Viral Therapy in Advanced Bladder CancerTerminatedPhase 2Binhui Biopharmaceutical Co., Ltd.NCT05248789Written as OH2 injection
- OH2 Oncolytic Viral Therapy in Pancreatic CancerTerminatedPhase 1/2Binhui Biopharmaceutical Co., Ltd.NCT04637698Written as OH2 injection